What type of drug is Teclistamab?

Teclistamab(Teclistamab) is a monoclonal antibody that binds to receptors on cancer cells, inducing an immune response and interfering with the cell's ability to grow and spread. The recommended dose of teritusumab is weekly subcutaneous injections (SC) of 1.5 mg/kg, followed by escalating doses of 0.06 mg/kg and 0.3 mg/kg. For patients who are in complete remission or improvement for at least 6 months, consider reducing the frequency of dosing to 1.5 mg/kg subcutaneously every two weeks. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.